U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Ceftaroline fosamil - Injection Products
  1. Development Resources

Ceftaroline fosamil - Injection Products

Recognized Interpretive Criteria

 

Minimum Inhibitory
Concentrations

(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

SDD*

I

R

S

SDD*

I

R

Enterobacterales

M100 standard is recognized

Staphylococcus aureus (including MRSA)

M100 standard is recognized

Haemophilus influenzae and parainfluenzae

M100 standard is recognized

Streptococcus pneumoniae

M100 standard is recognized

Streptococcus spp β- Hemolytic Group

M100 standard is recognized

S = Susceptible; SDD=Susceptible-dose dependent; I = Intermediate; R = Resistant
*The ceftaroline fosamil SDD category applies only to S. aureus (including MRSA)

Back to Top